Guardion Health Sciences, Inc. Gains 47.84%
Guardion Health Sciences, Inc. (GHSI:NASDAQ) soared at $0.28, a gain of 47.8%. The stock got featured on our News Catalysts scanner on Wed, Feb 23, 2022 at 07:04 PM in the 'PUBLIC OFFERING' category. From Tue, Feb 15, 2022, the stock recorded 25.00% Up Days and 22.22% Green Days
The stock spiked on Wed, Oct 27, 2021 at $1.98 with a volume of 86M+.
About Guardion Health Sciences, Inc. (GHSI:NASDAQ)
Guardion Health Sciences Inc is a specialty health sciences company formed to develop, formulate and distribute condition-specific medical foods with an initial medical food product. The company's Lumega-Z, is a micronized lipid-base nutritional formulation designed to restore and maintain the condition of a depleted macular pigment. It has also developed GlaucoCetin, the first regulated vision-specific Medical Food designed to support and protect the mitochondrial function of optic nerve cells in patients with glaucoma.
Top 10 Gainers:
- Viscogliosi Brothers Acquisition Corp (VBOC:NASDAQ), 100%
- Avenue Therapeutics, Inc. (ATXI:NASDAQ), 78.46%
- CTI BioPharma Corp. (CTIC:NASDAQ), 63.16%
- GBS Inc. (GBS:NASDAQ), 50%
- Guardion Health Sciences, Inc. (GHSI:NASDAQ), 47.84%
- CooTek (Cayman) Inc. (CTK:NYSE), 36.24%
- Trevi Therapeutics, Inc. (TRVI:NASDAQ), 36.11%
- Sky Harbour Group Corporation Class A (SKYH:NYSEMKT), 30.84%
- GWG Holdings, Inc. (GWGH:NASDAQ), 29.37%
- Avinger, Inc. (AVGR:NASDAQ), 28.31%